BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

OriGene Technologies Incorporated

OriGene, a gene discovery company, is engaged in the identification and validation of molecular drug targets. OriGene have developed a proprietary technology for high-throughput gene cloning and have identified numerous genes that are associated with the development of different human disorders. OriGene is actively engaged in establishing research alliances with pharmaceutical and biotech companies to extend our discoveries to the development of gene-based diagnostics and therapeutics.


Contact Details:
6 Taft Court, Suite 100
Rockville
MD
20850
United States of America
Tel:301-340-3188
Fax:
Email:
WWW:

www.origene.com/




Loading...

Recent Publications by OriGene Technologies Incorporated:

Application of siRNA against SARS in the rhesus macaque model.
Containment of the SARS coronavirus (SCV) outbreak was accompanied by the...
19th June, 2008
OriGene Technologies Inc, Rockville, MD, USA. Methods Mol Biol. 2008;442:139-58.
DOI Direct Link

BioNews Results for OriGene Technologies Incorporated:

OriGene Technologies Launches 5,000 Human Antigen Standards For Antibody Validation
Bioresearch Online:  Sep 16 2008 12:08AM Matching: origene technologies
OriGene Technologies Launches 5,000 Human Antigen Standards for Antibody Validation
KSLA:  Sep 16 2008 3:04AM Matching: origene technologies
OriGene Technologies Launches 5,000 Human Antigen Standards for Antibody Validation
Pharma Live:  Sep 16 2008 12:49PM Matching: origene technologies
OriGene Technologies Launches 5,000 Human Antigen Standards For Antibody Validation
Drug Discovery Online:  Sep 15 2008 9:00PM Matching: origene technologies
OriGene Technologies Launches 5,000 Human Antigen Standards for Antibody Validation
KLFY:  Sep 15 2008 8:55PM Matching: origene technologies
Promote your company here: BioNewsCast - Press Release Distribution

View more OriGene Technologies Incorporated news.

OriGene Technologies Incorporated Patents:

US Patent No.Title
7115393 Melanocortin-1 receptor and methods of use
7053193 Breast cancer transcription factor gene and uses
6953673 Histamine H2 receptor and uses
6833247 Regulated prostate cancer genes
6780595 Human Tbx20 gene and uses

View more OriGene Technologies Incorporated patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 164 times since April 2007, the link to the organisation's website has been followed 47 times

Recent Search Terms used to find this page: origene.com | origene | origene.com | origene.com usa | origene.com usa | .

Search for more companies in Rockville

Search for more companies in MD



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for OriGene Technologies Incorporated
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.